|
Live online
|
2027 |
2028 |
| Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec |
Jan |
Feb |
Mar |
|
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products
|
Animal Health |
|
6 |
|
|
|
|
|
2 |
|
|
|
|
|
A Practical Approach to Veterinary Vaccine Development and Registration in the EU
|
Animal Health |
|
|
|
|
|
22-23 |
|
|
|
|
|
|
|
AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects
|
Artificial Intelligence (AI) in Life Sciences |
|
10 |
|
|
|
|
|
12 |
|
|
|
|
|
AI in Healthcare: Governance, Risk & Strategic Adoption
New for 2027
|
Artificial Intelligence (AI) in Life Sciences |
|
|
|
|
|
21 |
|
|
|
|
|
|
|
APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence
|
GxP |
28-29 |
|
|
|
|
|
20-21 |
|
|
|
|
|
|
An Essential Overview of Medical Information
|
Vigilance |
|
|
21 |
|
|
|
|
|
2 |
|
|
|
|
An Introduction to Ethylene Oxide (EO) Sterilization for Medical Devices
|
Medical Devices |
|
13 |
|
|
|
|
|
8 |
|
|
|
|
|
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals
|
Medical Devices |
|
7 |
|
|
|
|
|
18 |
|
|
|
|
|
An Introduction to ISO 13485: 2016 - Quality Management System (QMS) for Medical Devices
|
Medical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
|
An Overview of EU and UK Regulatory Affairs
|
0 |
|
|
|
|
|
20-21 |
|
|
|
|
|
|
|
Animal Feed and Feed Additive Registration in China and Thailand
|
Animal Health |
15 |
|
|
|
|
|
21 |
|
|
|
|
|
|
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions
New for 2026
|
0 |
|
|
9 |
|
|
|
|
|
8 |
|
|
|
|
Biological Evaluation of Medical Devices
|
Medical Devices |
|
|
|
1-2 |
|
|
|
|
|
|
|
|
|
CAPA (Corrective and Preventative Action)
|
0 |
|
|
14 |
|
|
|
|
|
3 |
|
|
|
|
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products
|
GxP |
22-23 |
|
|
|
|
|
18-19 |
|
|
|
|
|
|
Cleanroom Requirements for Medical Device Manufacturers
|
Medical Devices |
|
|
|
|
|
20 |
|
|
|
|
|
|
|
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Applications
|
0 |
|
|
|
|
|
29-30 |
|
|
|
|
|
|
|
Clinical Quality Management Systems (CQMS): A Practical Guide to Inspection Readiness
|
Clinical Research |
|
|
|
|
|
16-17 |
|
|
|
|
|
|
|
Clinical Trial Regulatory Requirements
|
Clinical Research |
|
|
|
|
|
23-24 |
|
|
|
|
|
|
|
EU Pharmaceutical Regulations and Strategy
|
0 |
|
|
|
|
|
|
4-5 |
|
|
|
|
|
|
EU Proposed Pharmaceutical Legislation Changes
|
0 |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
FDA Approval Process for Medical Devices
|
Medical Devices |
|
24-25 |
|
|
|
|
|
30-1 |
|
|
|
|
|
How the Pharmaceutical and Biotech Industries Work: From Molecule to Market
|
0 |
|
|
|
|
|
27 |
|
|
|
|
|
|
|
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3
|
Animal Health |
12-13 |
|
|
|
|
|
14-15 |
|
|
|
|
|
|
Masterclass: Market Authorisation of AI-enabled Medical Devices
|
Artificial Intelligence (AI) in Life Sciences |
|
|
28-30 |
|
|
|
|
|
7-9 |
|
|
|
|
Mastering CTD Submissions in the MENA Region
|
0 |
|
25 |
|
|
|
|
|
25 |
|
|
|
|
|
Mastering Computer System Validation
|
GxP |
|
|
16-17 |
|
|
|
|
|
9-10 |
|
|
|
|
Medical Device Cybersecurity and Regulatory Compliance
|
Medical Devices |
|
|
|
|
|
30-1 |
|
|
|
|
|
|
|
Medical Device Regulation in the Eurasian Union, Russia and the CIS
|
Medical Devices |
|
|
29-30 |
|
|
|
|
|
7-8 |
|
|
|
|
Medical Device Regulations in Asia-Pacific Markets
|
Medical Devices |
|
|
|
|
|
15-16 |
|
|
|
|
|
|
|
Medical Device Regulations in the Middle East and North Africa
|
Medical Devices |
|
17-18 |
|
|
|
|
|
17-18 |
|
|
|
|
|
Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations
|
Medical Devices |
|
|
21-25 |
|
|
|
|
|
|
|
|
|
|
Navigating EU Product Classification: Foods, Supplements & Herbal Medicines Masterclass
Updated for 2026
|
0 |
|
|
10 |
|
|
|
|
|
3 |
|
|
|
|
Non-Conformance and Corrective Action for Medical Device Manufacturers
|
Medical Devices |
|
|
|
|
|
|
|
|
|
|
|
|
|
Orphan Drug Regulatory Masterclass: EU & US Insights
|
0 |
|
|
|
|
|
28 |
|
|
|
|
|
|
|
Pharmaceutical Regulatory Affairs in Asia
|
0 |
|
|
|
|
|
|
19-21 |
|
|
|
|
|
|
Pharmaceutical Regulatory Affairs in China
|
0 |
|
19-20 |
|
|
|
|
|
24-25 |
|
|
|
|
|
Pharmaceutical Regulatory Affairs in Russia, Eurasian Union and the CIS
|
0 |
|
|
|
|
|
29-30 |
|
|
|
|
|
|
|
Pharmaceutical Regulatory Affairs in the Middle East
|
0 |
12-13 |
|
|
|
|
|
19-20 |
|
|
|
|
|
|
Pharmaceutical Regulatory Affairs in the Middle East and North Africa
|
0 |
|
|
7-9 |
|
|
|
|
|
|
|
|
|
|
Regulatory Compliance and Safety Standards for Aesthetic Devices
New for 2026
|
Cosmetics |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sterilization of Medical Devices
|
Medical Devices |
22-23 |
|
|
|
|
|
11-12 |
|
|
|
|
|
|
The 2024 EU AI Act
New for 2026
|
Artificial Intelligence (AI) in Life Sciences |
|
|
22 |
|
|
|
|
|
2 |
|
|
|
|
The Common Technical Document
|
GxP |
13-14 |
|
|
|
|
|
20-21 |
|
|
|
|
|
|
The FDA Drug Approval Process
|
0 |
|
|
|
|
|
23-24 |
|
|
|
|
|
|
|
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry
|
0 |
19-20 |
|
|
|
|
|
11-12 |
|
|
|
|
|
|
UK Conformity Assessed (UKCA) Marking for Medical Devices
|
Medical Devices |
14 |
|
|
|
|
|
20 |
|
|
|
|
|
|
US FDA - Understanding Key Factors When Working with the FDA
|
Biopharma |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers
|
Medical Devices |
|
|
7 |
|
|
|
|
29 |
|
|
|
|
|
Variations to Marketing Authorisations
|
0 |
|
|
14-15 |
|
|
|
|
10-11 |
|
|
|
|
|
Veterinary Pharmaceutical Submissions in the EU
|
Animal Health |
|
17-18 |
|
|
|
|
|
18-19 |
|
|
|
|
|
Writing Inspection-Ready SOPs: Best Practice for Compliance and Control
|
0 |
|
6 |
|
|
|
|
|
25 |
|
|
|
|